Skip to menu Skip to content Skip to footer

Chemical mimics of bioactive protein surfaces (2006-2011)

Abstract

Proteins are the key functional components that define life, ageing, disease and death. Their uses in medicine, science and industry are extremely limited by their complexity, high costs, chemical instability and low bioavailability. This program will develop new chemical technology for creating simpler, smaller, cheaper, more stable and more bioavailable molecules that can execute selected functions of proteins. The approach involves devising stable new molecular shapes to mimic structural components of proteins (helices, turns, strands, and combinations), and using them as tools to interrogate biological systems and to explore prospective applications as new pharmaceuticals, diagnostics, vaccines, and nanomaterials.

Experts

Professor David Fairlie

Centre Director of The Centre for Chemistry and Drug Discovery
Centre for Chemistry and Drug Discovery
Institute for Molecular Bioscience
Affiliate of ARC COE for Innovations in Peptide and Protein Science
ARC COE for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
Centre Director of Institute for Molecular Bioscience
Institute for Molecular Bioscience
NHMRC Leadership Fellow and Group Leader
Institute for Molecular Bioscience
David Fairlie
David Fairlie